找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Radionuclide Therapy; Recep Beki?,Berna Polack,Murat Fani Bozkurt Book 2022 The Editor(s) (if applicable) and The Author(s), under exclusi

[復(fù)制鏈接]
查看: 43769|回復(fù): 52
樓主
發(fā)表于 2025-3-21 19:28:26 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Radionuclide Therapy
編輯Recep Beki?,Berna Polack,Murat Fani Bozkurt
視頻videohttp://file.papertrans.cn/821/820878/820878.mp4
概述Represents an extensive source of information in the field of radionuclide therapy.Explores the current status of radionuclide therapy.Includes medical treatment information in diseases treated with r
圖書封面Titlebook: Radionuclide Therapy;  Recep Beki?,Berna Polack,Murat Fani Bozkurt Book 2022 The Editor(s) (if applicable) and The Author(s), under exclusi
描述The main purpose of this book is to create a reference for the indications, contraindications, patient selection, treatment practice, treatment side effect management, and follow-up of radionuclide treatments.. .Besides standard methods such as surgery, chemotherapy, radiotherapy, and hormone therapy, newly developed biological treatments, targeted treatments, personalized treatments, external beam radiotherapy, and targeted radionuclide treatments have begun to take their place in professional practice.?.Nuclear medicine, in addition to its role as a tracer of cancer, also assumes the role of treating with radioactive molecules directed to the cancer it traces. These traceable next-generation radionuclide treatments, whose efficacy and reliability have been proven and where diagnosis, treatment, and follow-up are carried out together, are increasingly included in oncology practice together with the new developed radiopharmaceuticals, ensuring a high rate of damage to cancer cells while protecting the surrounding normal tissues. Molecular cancer treatment will become more effective with individualized next-generation traceable radionuclide treatments, which will be shaped by geneti
出版日期Book 2022
關(guān)鍵詞Nuclear Medicine; Radiation; Radiopharmacy; Surgery; Hematology
版次1
doihttps://doi.org/10.1007/978-3-030-97220-2
isbn_softcover978-3-030-97222-6
isbn_ebook978-3-030-97220-2
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

書目名稱Radionuclide Therapy影響因子(影響力)




書目名稱Radionuclide Therapy影響因子(影響力)學(xué)科排名




書目名稱Radionuclide Therapy網(wǎng)絡(luò)公開度




書目名稱Radionuclide Therapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Radionuclide Therapy被引頻次




書目名稱Radionuclide Therapy被引頻次學(xué)科排名




書目名稱Radionuclide Therapy年度引用




書目名稱Radionuclide Therapy年度引用學(xué)科排名




書目名稱Radionuclide Therapy讀者反饋




書目名稱Radionuclide Therapy讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:54:47 | 只看該作者
板凳
發(fā)表于 2025-3-22 04:16:50 | 只看該作者
Radionuclide Therapy in Neuroectodermal TumorsHigh-dose I-131 MIBG treatment in combination with megatherapy and stem cell transplantation in the high-risk patient group included in TPOG Neuroblastoma treatment protocol (NB2009) is carried out in a limited number of centers in Turkey since experienced personnel and equipped centers are required for this treatment.
地板
發(fā)表于 2025-3-22 05:06:25 | 只看該作者
Systemic Treatments and Related Side Effects in Neuroectodermal Tumors tumors in the WHO brain tumor classification published in 2016 [2]. This group includes medulloblastoma, neuroblastoma, ganglioneuroblastoma, medulloepithelioma, ependymoblastoma, and atypical teratoid/rhabdoid tumors. Most of the PNETs are located outside the CNS are from Ewing family of tumors.
5#
發(fā)表于 2025-3-22 09:22:07 | 只看該作者
des medical treatment information in diseases treated with rThe main purpose of this book is to create a reference for the indications, contraindications, patient selection, treatment practice, treatment side effect management, and follow-up of radionuclide treatments.. .Besides standard methods suc
6#
發(fā)表于 2025-3-22 13:12:40 | 只看該作者
7#
發(fā)表于 2025-3-22 20:12:44 | 只看該作者
8#
發(fā)表于 2025-3-22 23:14:34 | 只看該作者
9#
發(fā)表于 2025-3-23 04:08:05 | 只看該作者
Basic Properties and Preparation of Radiopharmaceuticals Used in Radionuclide Therapyiation is sent to the disease areas, thus providing treatment, control, or pain palliation of the disease. Damages caused by ionized radiation such as single or double-strand breaks in cell DNA and DNA base changes play a role in the effectiveness of treatment. A therapeutic radiopharmaceutical is a
10#
發(fā)表于 2025-3-23 06:00:11 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 06:29
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
咸宁市| 桃园县| 长汀县| 堆龙德庆县| 婺源县| 延吉市| 张家口市| 赣州市| 梅河口市| 永靖县| 新干县| 中宁县| 安远县| 剑川县| 上杭县| 县级市| 乌拉特后旗| 双柏县| 库伦旗| 合川市| 望都县| 靖安县| 旬阳县| 喀喇沁旗| 安龙县| 玛纳斯县| 连江县| 新安县| 马尔康县| 唐海县| 诸暨市| 新蔡县| 荆门市| 辰溪县| 乃东县| 隆德县| 黔西| 玉龙| 武功县| 监利县| 永州市|